Imunon, Inc. Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration
Imunon, Inc. (IMNN) had Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration of $10.40 million as of 2033-12-31, per its 10-K filed 2014-03-13.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration · last filed 2018-03-27
- 2033-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration $10.40M.
- 2032-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration $20.56M; Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration as first filed $20.59M.
- 2031-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration $21.39M.
- 2030-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration $18.14M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration | Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration as first filed |
|---|---|---|
| 2033-12-31 | $10.40M 10-K · filed 2014-03-13 | |
| 2032-12-31 | $20.56M 10-K · filed 2014-03-13 | $20.59M 10-K · filed 2013-03-18 |
| 2031-12-31 | $21.39M 10-K · filed 2014-03-13 | |
| 2030-12-31 | $18.14M 10-K · filed 2014-03-13 | |
| 2029-12-31 | $18.55M 10-K · filed 2014-03-13 | |
| 2028-12-31 | $11.90M 10-K · filed 2014-03-13 | |
| 2026-12-31 | $7.36M 10-K · filed 2014-03-13 | |
| 2025-12-31 | $8.17M 10-K · filed 2014-03-13 | |
| 2024-12-31 | $15.65M 10-K · filed 2014-03-13 | |
| 2023-12-31 | $2.29M 10-K · filed 2014-03-13 | |
| 2022-12-31 | $4.84M 10-K · filed 2014-03-13 | |
| 2017-12-31 | $225.42M 10-K · filed 2018-03-27 | |
| 2016-12-31 | $204.86M 10-K · filed 2017-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |